Literature DB >> 23250032

Baculoviral inhibitors of apoptosis repeat containing (BIRC) proteins fine-tune TNF-induced nuclear factor κB and c-Jun N-terminal kinase signalling in mouse pancreatic beta cells.

B M Tan1, N W Zammit, A O Yam, R Slattery, S N Walters, E Malle, S T Grey.   

Abstract

AIMS/HYPOTHESIS: For beta cells, contact with TNF-α triggers signalling cascades that converge on pathways important for cell survival and inflammation, specifically nuclear factor κB (NF-κB), c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase pathways. Here, we investigated the function of baculoviral inhibitors of apoptosis repeat containing (BIRC) proteins in regulating TNF signalling cascades.
METHODS: TNF regulation of Birc genes was studied by mRNA expression and promoter analysis. Birc gene control of cell signalling was studied in beta cell lines, and in islets from Birc2(-/-) and Birc3(-/-) mice, and from Birc3(-/-) Birc2Δ beta cell mice that selectively lack Birc2 and Birc3 (double knockout [DKO]). Islet function was tested by intraperitoneal glucose tolerance test and transplantation.
RESULTS: TNF-α selectively induced Birc3 in beta cells, which in turn was sufficient to drive and potentiate NF-κB reporter activity. Conversely, Birc3(-/-) islets exhibited delayed TNF-α-induced IκBα degradation with reduced expression of Ccl2 and Cxcl10. DKO islets showed a further delay in IκBα degradation kinetics. Surprisingly, DKO islets exhibited stimulus-independent and TNF-dependent hyperexpression of TNF target genes A20 (also known as Tnfaip3), Icam1, Ccl2 and Cxcl10. DKO islets showed hyperphosphorylation of the JNK-substrate, c-Jun, while a JNK-antagonist prevented increases of Icam1, Ccl2 and Cxcl10 expression. Proteosome blockade of MIN6 cells phenocopied DKO islets. DKO islets showed more rapid loss of glucose homeostasis when challenged with the inflammatory insult of transplantation. CONCLUSIONS/
INTERPRETATION: BIRC3 provides a feed-forward loop, which, with BIRC2, is required to moderate the normal speed of NF-κB activation. Paradoxically, BIRC2 and BIRC3 act as a molecular brake to rein in activation of the JNK signalling pathway. Thus BIRC2 and BIRC3 fine-tune NF-κB and JNK signalling to ensure transcriptional responses are appropriately matched to extracellular inputs. This control is critical for the beta cell's stress response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23250032     DOI: 10.1007/s00125-012-2784-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  50 in total

1.  Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.

Authors:  Hasem Habelhah; Shoichi Takahashi; Ssang-Goo Cho; Takayuki Kadoya; Toshiki Watanabe; Ze'ev Ronai
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598

2.  NF-kappaB dictates the degradation pathway of IkappaBalpha.

Authors:  Erika Mathes; Ellen L O'Dea; Alexander Hoffmann; Gourisankar Ghosh
Journal:  EMBO J       Date:  2008-04-10       Impact factor: 11.598

3.  Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function.

Authors:  Shane T Grey; Christopher Longo; Tala Shukri; Virendra I Patel; Eva Csizmadia; Soizic Daniel; Maria B Arvelo; Vaja Tchipashvili; Christiane Ferran
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

4.  TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival.

Authors:  S Y Lee; A Reichlin; A Santana; K A Sokol; M C Nussenzweig; Y Choi
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

5.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.

Authors:  M A Kelliher; S Grimm; Y Ishida; F Kuo; B Z Stanger; P Leder
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

6.  IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

Authors:  James E Vince; W Wei-Lynn Wong; Nufail Khan; Rebecca Feltham; Diep Chau; Afsar U Ahmed; Christopher A Benetatos; Srinivas K Chunduru; Stephen M Condon; Mark McKinlay; Robert Brink; Martin Leverkus; Vinay Tergaonkar; Pascal Schneider; Bernard A Callus; Frank Koentgen; David L Vaux; John Silke
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

7.  Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.

Authors:  T Henkel; T Machleidt; I Alkalay; M Krönke; Y Ben-Neriah; P A Baeuerle
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

Review 8.  IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.

Authors:  Mads Gyrd-Hansen; Pascal Meier
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

9.  In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.

Authors:  S V Pakala; M Chivetta; C B Kelly; J D Katz
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

10.  Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.

Authors:  Brian J Zarnegar; Yaya Wang; Douglas J Mahoney; Paul W Dempsey; Herman H Cheung; Jeannie He; Travis Shiba; Xiaolu Yang; Wen-Chen Yeh; Tak W Mak; Robert G Korneluk; Genhong Cheng
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more
  8 in total

1.  Tumor necrosis factor α-induced protein-3 protects zinc transporter 8 against proinflammatory cytokine-induced downregulation.

Authors:  Liqing Cheng; Dongmei Zhang; Bing Chen
Journal:  Exp Ther Med       Date:  2016-06-15       Impact factor: 2.447

2.  Comparative analysis of signaling pathways in peripheral blood from patients with Kashin-Beck disease and osteoarthritis.

Authors:  Yujie Ning; Xi Wang; Sen Wang; Xiong Guo
Journal:  Exp Ther Med       Date:  2016-11-07       Impact factor: 2.447

3.  Effect and mechanisms of human Wharton's jelly-derived mesenchymal stem cells on type 1 diabetes in NOD model.

Authors:  Jianxia Hu; Yangang Wang; Fang Wang; Luan Wang; Xiaolong Yu; Ruixia Sun; Zhongchao Wang; Li Wang; Hong Gao; Zhengju Fu; Wenjuan Zhao; Shengli Yan
Journal:  Endocrine       Date:  2014-03-04       Impact factor: 3.633

4.  A20 as an immune tolerance factor can determine islet transplant outcomes.

Authors:  Nathan W Zammit; Stacey N Walters; Karen L Seeberger; Philip J O'Connell; Gregory S Korbutt; Shane T Grey
Journal:  JCI Insight       Date:  2019-11-01

5.  Generalized multi-SNP mediation intersection-union test.

Authors:  Wujuan Zhong; Toni Darville; Xiaojing Zheng; Jason Fine; Yun Li
Journal:  Biometrics       Date:  2021-01-13       Impact factor: 2.571

6.  Gene expression signature in endemic osteoarthritis by microarray analysis.

Authors:  Xi Wang; Yujie Ning; Feng Zhang; Fangfang Yu; Wuhong Tan; Yanxia Lei; Cuiyan Wu; Jingjing Zheng; Sen Wang; Hanjie Yu; Zheng Li; Mikko J Lammi; Xiong Guo
Journal:  Int J Mol Sci       Date:  2015-05-19       Impact factor: 5.923

7.  Graph theoretic network analysis reveals protein pathways underlying cell death following neurotropic viral infection.

Authors:  Sourish Ghosh; G Vinodh Kumar; Anirban Basu; Arpan Banerjee
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

8.  Functional cytochrome P450 1A enzymes are induced in mouse and human islets following pollutant exposure.

Authors:  Muna Ibrahim; Erin M MacFarlane; Geronimo Matteo; Myriam P Hoyeck; Kayleigh R C Rick; Salar Farokhi; Catherine M Copley; Shannon O'Dwyer; Jennifer E Bruin
Journal:  Diabetologia       Date:  2019-11-27       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.